ENETS Abstract Search

Comparison of the Utility of Biochemical Markers in Predicting the Presence and Severity of Carcinoid Heart Disease

#671

Introduction: Carcinoid heart disease (CHD) is a complication of metastatic neuroendocrine disease and is screened for using echocardiography.

Aim(s): We sought to determine the best diagnostic marker for the presence and severity of CHD in patients with neuroendocrine tumors (NETs).

Materials and methods: One-hundred and eighty-eight patients with NETs, liver metastases and/or carcinoid syndrome were prospectively recruited. Serum and plasma analysed for: Chromogranin A (CgA), Chromogranin B, N-terminal proBrain Natriuretic Peptide (NT-proBNP), Neurokinin A & plasma 5-Hydroxyindoleacetic acid (5HIAA). Patients underwent echocardiography performed by one experienced operator to determine presence/absence of CHD (thickened, immobile and regurgitant right-sided valve). A carcinoid heart score (CHS) was calculated (range 0-66, higher scores indicating increasing valvular pathology).

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author:

Authors: Dobson R, Burgess M, Chadwick C, Vora J, Pritchard M,

Keywords: carcinoid heart, biomarker,

To read the full abstract, please log into your ENETS Member account.